Evidence map›Paper›PMID 38910935›Full record

ArticleWellcome open research2022

Piloting the adaptation of the Kaufman Assessment Battery for Children-2

Joseph D Piper, Clever Mazhanga, Gloria Mapako, Idah Mapurisa, Tsitsi Mashedze, Eunice Munyama, Marian Mwapaura, Dzivaidzo Chidhanguro, Grace Gerema, Naume V Tavengwa and 9 more

Abstract read
In one paragraph

Article in Wellcome open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Joseph D PiperDepartment of Genomics and Child Health, Queen Mary University of London, London, E1 4AT, UK.ORCID https://orcid.org/0000-0003-3408-7792
Clever MazhangaZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Gloria MapakoZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Idah MapurisaZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Tsitsi MashedzeZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Eunice MunyamaZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Marian MwapauraZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Dzivaidzo ChidhanguroZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Grace GeremaZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Naume V TavengwaZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.
Robert NtoziniZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.ORCID https://orcid.org/0000-0002-8543-2835
Lisa F LanghaugZvitambo Institute for Maternal and Child Health Research, Mabelreign, Harare, Zimbabwe.ORCID https://orcid.org/0000-0002-9131-8158
Melanie SmukDepartment of Genomics and Child Health, Queen Mary University of London, London, E1 4AT, UK.ORCID https://orcid.org/0000-0002-1594-1458
Tamsen RochatDepartment of Psychology, University of the Witwatersrand, Johannesburg, 2000, South Africa.
Alan KaufmanDepartment of Medicine, Yale University, New Haven, Connecticut, 06520-8081, USA.
Nadeen KaufmanDepartment of Medicine, Yale University, New Haven, Connecticut, 06520-8081, USA.
Melissa GladstoneDepartment of Life Course and Medical Sciences, University of Liverpool, Liverpool, L69 7ZX, UK.ORCID https://orcid.org/0000-0002-2579-9301
Elizabeth AllenDepartment of Life Course and Medical Sciences, University of Liverpool, Liverpool, L69 7ZX, UK.
Andrew J PrendergastDepartment of Genomics and Child Health, Queen Mary University of London, London, E1 4AT, UK.

Funding

Clinical outcomes of HIV-exposed uninfected children during mid-childhood in rural ZimbabweR33HD103101 · NICHD · ZVITAMBO INSTITUTE FOR MATERNAL AND CHILD HEALTH RESEARCH · PI PRENDERGAST, ANDREW · 2023 to 2025
$1.0M
Clinical outcomes of HIV-exposed uninfected children during mid-childhood in rural ZimbabweR61HD103101 · NICHD · ZVITAMBO INSTITUTE FOR MATERNAL AND CHILD HEALTH RESEARCH · PI PRENDERGAST, ANDREW · 2020 to 2021
$614k
NICHD NIH HHS R33 HD103101NICHD NIH HHS R61 HD103101Wellcome Trust
6 · The paper itself

Abstract

Background: Neurodevelopment assessment tools for low-resource settings are urgently needed. However, most available tools were developed in high-income settings and may lack cross-cultural validity. Methods: We piloted and adapted two subtests within the planning domain of the Kaufman Assessment Battery for Children-2nd edition (KABC-II) for use in rural Zimbabwean children aged 7years. After initial assessments of face validity, we created 4 substitutions for the story completion subtest and 7 additions for the pattern reasoning subtest through a co-design process with fieldworkers and child development experts. To assess how successful the changes were, T-tests adjusting for unequal variances were used to compare scores between the original and adapted versions of the same subtest. ANOVA and pairwise analysis was performed to compare the performance of KABC-II subtests across domains. Intraclass correlation coefficient was calculated to explore the variability between domains. Results: Initial test scores on the planning domain were significantly lower than the other three domains of learning, sequential memory and simultaneous reasoning (P<0.001) in 50 children (mean age 7.6(SD 0.2) years). Modified subtests were administered to another 20 children (mean age 7.6(SD 0.2) years), who showed story completion scores that were 0.7 marks higher (95% CI 0.0, 1.4; P=0.05) and pattern reasoning scores 1.8 marks higher (95% CI 0.5, 3.2; P=0.01). Overall, the planning domain mean score increased from 8.1 (SD 2.9) to 10.6 (SD 3.4). The intra class correlation coefficient between all four KABC-II domains was initially 0.43 (95% CI 0.13, 0.64) and after modification was 0.69 (95% CI 0.37, 0.87), suggesting an increase in the construct validity. Conclusions: The KABC-II planning domain was successfully adapted to improve cross-cultural validity. Construct validity was enhanced, based on increased inter-correlations among scales. The process of co-design to modify tests for new settings may be beneficial for other commonly used neurodevelopmental tools.

Indexed as

Child developmentcognitionSchool-ageSub-Saharan Africa

Identifiers

PMID38910935
PMCPMC11190652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.